Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

In the S0313 trial, we evaluated the impact of adding ibritumomab tiuxetan consolidation to 3 cycles of standard cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy plus involved field radiotherapy (IFRT) in patients with limited-stage aggressive B-cell non-Hodgkin lymphom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Persky, Daniel O., Miller, Thomas P., Unger, Joseph M., Spier, Catherine M., Puvvada, Soham, Stea, B. Dino, Press, Oliver W., Constine, Louis S., Barton, Kevin P., Friedberg, Jonathan W., LeBlanc, Michael, Fisher, Richard I.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2015
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4287635/
https://ncbi.nlm.nih.gov/pubmed/25395425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-584623
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados